(-0.58%) 5 022.21 points
(-0.12%) 37 753 points
(-1.15%) 15 683 points
(-3.03%) $82.77
(-1.04%) $1.714
(-0.81%) $2 388.30
(-0.07%) $28.36
(-2.20%) $953.70
(-0.46%) $0.937
(0.19%) $11.00
(-0.21%) $0.803
(0.14%) $94.27
Live Chart Being Loaded With Signals
Gan & Lee Pharmaceuticals., a biopharmaceutical company, engages in the research, development, production, and commercialization insulin analogues primarily in China...
Stats | |
---|---|
Today's Volume | 12.19M |
Average Volume | 11.18M |
Market Cap | 25.32B |
EPS | CNY0.227 ( 2023-10-30 ) |
Last Dividend | CNY0 ( N/A ) |
Next Dividend | CNY0 ( N/A ) |
P/E | 99.79 |
ATR14 | CNY0.0540 (0.13%) |
Volume Correlation
Gan & Lee Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Gan & Lee Correlation - Currency/Commodity
Gan & Lee Financials
Annual | 2022 |
Revenue: | CNY1.71B |
Gross Profit: | CNY1.31B (76.30 %) |
EPS: | CNY-0.780 |
Q3 | 2023 |
Revenue: | CNY675.91M |
Gross Profit: | CNY517.37M (76.54 %) |
EPS: | CNY0.240 |
Q2 | 2023 |
Revenue: | CNY671.77M |
Gross Profit: | CNY499.94M (74.42 %) |
EPS: | CNY0.150 |
Q1 | 2023 |
Revenue: | CNY558.00M |
Gross Profit: | CNY407.17M (72.97 %) |
EPS: | CNY0.0877 |
Financial Reports:
No articles found.
Gan & Lee
Gan & Lee Pharmaceuticals., a biopharmaceutical company, engages in the research, development, production, and commercialization insulin analogues primarily in China. Its products include Basalin, an insulin glargine injection; Prandilin, an insulin lispro injection; Prandilin 25, an insulin lispro; Raplin, an insulin aspart injection; Raplin 30, an insulin aspart 30 injection; and Similin 30, an insulin injection, as well as medical devices. The company was formerly known as Beijing Gan & Lee Biotechnology Co., Ltd. and changed its name to Gan & Lee Pharmaceuticals. in April 2005. Gan & Lee Pharmaceuticals. was founded in 1998 and is headquartered in Beijing, the People's Republic of China.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators